Andy Round, investment director at SPARK Impact took part in the University of Liverpool and Bionow Research and Innovation event yesterday.
The full day conference was attended by over 100 life science professionals to help facilitate engagement between industry and the University of Liverpool.
The keynote address was given by Dr Richard Weaver, Associate Scientific Director, at Servier who spoke about Drug Safety and the Successful Collaboration with University of Liverpool.
Throughout the day there were 4 sessions focusing on key topics such as Biomakers, Enabling Technology, Therapeutics and Translation.
Andy who attended the event on behalf of SPARK Impact gave a talk on Funding for Translations and how Biomarkers & Therapeutics can be facilitated and appropriate funding can be secured which was followed by a lively Q&A discussion.